We partner with top biotech, pharmaceutical, and academic organizations to amplify their research programs with actionable biological insights. Learn how the Enable Medicine Platform can work for your team.
More coming soon...
3D sphere vector

Partner with us

Leverage Enable Medicine's integrated platform to derive actionable insights and meet your program timelines.

Supercharge your research and accelerate your pipeline

Understanding your drug and indication with high resolution
Enable Medicine's domain-level expertise, powerful data analytics, and state-of-the-art spatial biology lab reduce risk and increase probability of your program’s success .
Make decisions backed by deep insights and robust data interpretation
Tired of siloed data storage and disjointed analysis infrastructure? Enable Medicine bridges comprehensive cloud biodata infrastructure with best-in-class AI/ML research and methods for targeted biological discovery.
Deep, AI-powered insights to guide your drug development pipeline and improve trial design.
Uncover new mechanisms of action
  • What are the underlying molecular pathways and interactions associated with the observed therapeutic effects of this drug in this disease?
  • How does this pathway contribute to the progression of this disease, and can targeting it lead to novel therapeutic interventions?
  • Are there previously unrecognized cellular targets that play a critical role in the mechanism of action of established medicines like this drug?
Validate new targets
  • Can genetic or pharmacological manipulation of this target replicate the observed therapeutic effects seen in preclinical models?
  • What evidence supports the role of this gene as a viable therapeutic target, and how can its relevance be validated in disease models and patient samples?
  • Are there synergistic effects between targeting this target and existing therapies, and can this combination enhance therapeutic outcomes?
Develop new biomarkers
  • What molecular or cellular markers correlate with treatment response to this drug in patients with this disease?
  • Can circulating biomarkers, such as this biomarker, be identified and validated as indicators of disease progression or therapeutic efficacy?
  • How can imaging technologies and liquid biopsy approaches be employed to discover and validate predictive biomarkers for this disease?
Define therapeutic strategies
  • What combination therapies, involving this drug, demonstrate enhanced efficacy and reduced side effects in treating this disease?
  • How can precision medicine approaches be employed to tailor therapeutic interventions to patients with this disease?
  • What is the optimal treatment duration and dosage regimen for this therapeutic approach to achieve sustained therapeutic effects?
Design clinical trials
  • What patient populations are most likely to benefit from this therapeutic approach, and how can these subsets be identified for enrollment in clinical trials?
  • What are the most appropriate surrogate endpoints or biomarkers for assessing the efficacy of this therapeutic approach in early-phase clinical trials?
  • How can innovative trial designs be utilized to efficiently evaluate the safety and efficacy of this therapeutic approach in multiple patient cohorts?
See the Enable Medicine platform in action
All research
November 1, 2023
PEPSI: Polarity measurements from spatial proteomics imaging suggest immune cell engagement
November 1, 2023
A machine learning toolkit for automated processing of multiplexed immunofluorescence images
Get started with Enable Medicine
Leverage Enable Medicine's integrated platform to derive actionable insights and meet your program timelines.
Partner with us